Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 88

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 88
---
ii) 189,012 NLS Common Shares held by Revel Family Ltd., and (iii) 189,012 NLS Common Shares issuable upon exercise of common warrants held by Revel Family Ltd. exercisable within 60 days of August 28, 2025, subject to a beneficial ownership limitation of 9.99%. Revel Family Ltd. is controlled by Michel Revel, its sole equity owner, who holds voting and dispositive power over the securities. The address of Revel Family Ltd. is 52 HaNasi HaRishon Street, Rehovot, Israel, 7630242. (3)Consists of (i) 438,169 NLS Common Shares, (ii) 3,474 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of August 28, 2025, (iii) 13,054 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of August 28, 2025, (iv) 100,807 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of August 28, 2025, subject to a beneficial ownership limitation of 9.99%, and (v) 1,925 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of August 28, 2025, subject to a beneficial ownership limitation of 4.99%. The beneficial ownership limitation restricts from exercising that portion of the warrants that would result in Mr. Ronald Hafner owning, after exercise, a number of NLS Common Shares in excess of the beneficial ownership limitation. Mr. Hafner is Chairman of NLS Pharmaceutics Ltd. (4)Consists of (i) 2,058,573 NLS Common Shares, (ii) 232,686 Common Shares issuable upon vesting of RSUs and exercisable within 60 days of August 28, 2025, and (iii) 452,224 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of August 28, 2025. (5)Consists of 1,742 NLS Common Shares issuable upon exercise of options within 60 days of August 28, 2025. (6)Consists of 1,248 NLS Common Shares. (7)Consists of (i) 48,528